-
1
-
-
0034729726
-
Enkephalin glycopeptide analogues produce analgesia with reduced dependence liability
-
DOI 10.1021/jm000077y
-
E.J. Bilsky, R.D. Egleton, S.A. Mitchell, M.M. Palian, P. Davis, J.D. Huber, H. Jones, H.I. Yamamura, J. Janders, T.P. Davis, F. Porreca, V.J. Hruby, and R. Polt Enkephalin glycopeptide analogues produce analgesia with reduced dependence liability J. Med. Chem. 43 2000 2586 2590 (Pubitemid 30437141)
-
(2000)
Journal of Medicinal Chemistry
, vol.43
, Issue.13
, pp. 2586-2590
-
-
Bilsky, E.J.1
Egleton, R.D.2
Mitchell, S.A.3
Palian, M.M.4
Davis, P.5
Huber, J.D.6
Jones, H.7
Yamamura, H.I.8
Janders, J.9
Davis, T.P.10
Porreca, F.11
Hruby, V.J.12
Polt, R.13
-
2
-
-
26844505808
-
Toxin-induced models of Parkinson's disease
-
DOI 10.1602/neurorx.2.3.484
-
J. Bové, D. Prou, C. Perier, and S. Przedborski Toxin-induced models of Parkinson's disease NeuroRx 2 2005 484 494 (Pubitemid 41444882)
-
(2005)
NeuroRx
, vol.2
, Issue.3
, pp. 484-494
-
-
Bove, J.1
Prou, D.2
Perier, C.3
Przedborski, S.4
-
3
-
-
0027765503
-
Differential processing of proenkephalin by prohormone convertases 1(3) and 2 and furin
-
M.B. Breslin, I. Lindberg, S. Benjannet, J.P. Mathis, C. Lazure, and N.G. Seidah Differential processing of proenkephalin by prohormone convertases 1(3) and 2 and furin J. Biol. Chem. 268 1993 27084 27093 (Pubitemid 24006422)
-
(1993)
Journal of Biological Chemistry
, vol.268
, Issue.36
, pp. 27084-27093
-
-
Breslin, M.B.1
Lindberg, I.2
Benjannet, S.3
Mathis, J.P.4
Lazure, C.5
Seidah, N.G.6
-
4
-
-
0036159502
-
Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias
-
F. Calon, S. Birdi, A.H. Rajput, O. Hornykiewicz, P.J. Bedard, and T. Di Paolo Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias J. Neuropathol. Exp. Neurol. 61 2002 186 196 (Pubitemid 34127102)
-
(2002)
Journal of Neuropathology and Experimental Neurology
, vol.61
, Issue.2
, pp. 186-196
-
-
Calon, F.1
Birdi, S.2
Rajput, A.H.3
Hornykiewicz, O.4
Bedard, P.J.5
Di Paolo, T.6
-
5
-
-
0031925945
-
L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA
-
DOI 10.1046/j.1460-9568.1998.00285.x
-
M.A. Cenci, C.S. Lee, and A. Bjorklund l-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA Eur. J. Neurosci. 10 1998 2694 2706 (Pubitemid 28362576)
-
(1998)
European Journal of Neuroscience
, vol.10
, Issue.8
, pp. 2694-2706
-
-
Cenci, M.A.1
Lee, C.S.2
Bjorklund, A.3
-
6
-
-
0027332132
-
BW373U86: A nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells
-
S.R. Childers, L.M. Fleming, D.E. Selley, R.W. McNutt, and K.J. Chang BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells Mol. Pharmacol. 44 1993 827 834
-
(1993)
Mol. Pharmacol.
, vol.44
, pp. 827-834
-
-
Childers, S.R.1
Fleming, L.M.2
Selley, D.E.3
McNutt, R.W.4
Chang, K.J.5
-
7
-
-
0017927926
-
Evidence for a long Leu-enkephalin striopallidal pathway in rat brain
-
A.C. Cuello, and G. Paxinos Evidence for a long Leu-enkephalin striopallidal pathway in rat brain Nature 271 1978 178 180 (Pubitemid 8251637)
-
(1978)
Nature
, vol.271
, Issue.5641
, pp. 178-180
-
-
Cuello, A.C.1
Paxinos, G.2
-
8
-
-
33947302427
-
Modulation of l-DOPA-induced abnormal involuntary movements by clinically tested compounds: Further validation of the rat dyskinesia model
-
DOI 10.1016/j.bbr.2007.01.013, PII S0166432807000460
-
A. Dekundy, M. Lundblad, W. Danysz, and M.A. Cenci Modulation of l-DOPA-induced abnormal involuntary movements by clinically tested compounds: further validation of the rat dyskinesia model Behav. Brain Res. 179 2007 76 89 (Pubitemid 46441485)
-
(2007)
Behavioural Brain Research
, vol.179
, Issue.1
, pp. 76-89
-
-
Dekundy, A.1
Lundblad, M.2
Danysz, W.3
Cenci, M.A.4
-
9
-
-
53849119185
-
Behavioral pharmacology of the mu/delta opioid glycopeptide MMP2200 in rhesus monkeys
-
G.P. Do Carmo, R. Polt, E.J. Bilsky, K.C. Rice, and S.S. Negus Behavioral pharmacology of the mu/delta opioid glycopeptide MMP2200 in rhesus monkeys J. Pharmacol. Exp. Ther. 326 2008 939 948
-
(2008)
J. Pharmacol. Exp. Ther.
, vol.326
, pp. 939-948
-
-
Do Carmo, G.P.1
Polt, R.2
Bilsky, E.J.3
Rice, K.C.4
Negus, S.S.5
-
10
-
-
0031128414
-
Enhancement of the behavioral response to apomorphine administration following repeated treatment in the 6-hydroxydopamine-lesioned rat is temporally correlated with a rise in striatal preproenkephalin-B, but not preproenkephalin-A, gene expression
-
DOI 10.1006/exnr.1997.6431
-
S. Duty, and J.M. Brotchie Enhancement of the behavioral response to apomorphine administration following repeated treatment in the 6-hydroxydopamine-lesioned rat is temporally correlated with a rise in striatal preproenkephalin-B, but not preproenkephalin-A, gene expression Exp. Neurol. 144 1997 423 432 (Pubitemid 27224570)
-
(1997)
Experimental Neurology
, vol.144
, Issue.2
, pp. 423-432
-
-
Duty, S.1
Brotchie, J.M.2
-
11
-
-
0035200718
-
Improved blood-brain barrier penetration and enhanced analgesia of an opioid peptide by glycosylation
-
R.D. Egleton, S.A. Mitchell, J.D. Huber, M.M. Palian, R. Polt, and T.P. Davis Improved blood-brain barrier penetration and enhanced analgesia of an opioid peptide by glycosylation J. Pharmacol. Exp. Ther. 299 2001 967 972 (Pubitemid 33104967)
-
(2001)
Journal of Pharmacology and Experimental Therapeutics
, vol.299
, Issue.3
, pp. 967-972
-
-
Egleton, R.D.1
Mitchell, S.A.2
Huber, J.D.3
Palian, M.M.4
Polt, R.5
Davis, T.P.6
-
12
-
-
19944434130
-
Biousian glycopeptides penetrate the blood-brain barrier
-
DOI 10.1016/j.tetasy.2004.11.038, PII S0957416604008869
-
R.D. Egleton, E.J. Bilsky, G. Tollin, D. Muthu, J.J. Lowery, I. Alves, P. Davis, F. Porreca, H.I. Yamamura, L. Yeomans, C.M. Keyari, and R. Polt Biousian glycopeptides penetrate the blood-brain barrier Tetrahedron-Asymmetry 16 2005 65 75 (Pubitemid 40127076)
-
(2005)
Tetrahedron Asymmetry
, vol.16
, Issue.1
, pp. 65-75
-
-
Egleton, R.D.1
Bilsky, E.J.2
Tollin, G.3
Dhanasekaran, M.4
Lowery, J.5
Alves, I.6
Davis, P.7
Porreca, F.8
Yamamura, H.I.9
Yeomans, L.10
Keyari, C.M.11
Polt, R.12
-
13
-
-
4644258417
-
Antinociceptive structure-activity studies with enkephalin-based opioid glycopeptides
-
DOI 10.1124/jpet.104.069393
-
N.O. Elmagbari, R.D. Egleton, M.M. Palian, J.J. Lowery, W.R. Schmid, P. Davis, E. Navratilova, M. Dhanasekaran, C.M. Keyari, H.I. Yamamura, F. Porreca, V.J. Hruby, R. Polt, and E.J. Bilsky Antinociceptive structure-activity studies with enkephalin-based opioid glycopeptides J. Pharmacol. Exp. Ther. 311 2004 290 297 (Pubitemid 39287808)
-
(2004)
Journal of Pharmacology and Experimental Therapeutics
, vol.311
, Issue.1
, pp. 290-297
-
-
Elmagbari, N.O.1
Egleton, R.D.2
Palian, M.M.3
Lowery, J.J.4
Schmid, W.R.5
Davis, P.6
Navratilova, E.7
Dhanasekaran, M.8
Keyari, C.M.9
Yamamura, H.I.10
Porreca, F.11
Hruby, V.J.12
Polt, R.13
Bilsky, E.J.14
-
14
-
-
0025765058
-
Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats
-
T.M. Engber, Z. Susel, S. Kuo, C.R. Gerfen, and T.N. Chase Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats Brain Res. 552 1991 113 118
-
(1991)
Brain Res.
, vol.552
, pp. 113-118
-
-
Engber, T.M.1
Susel, Z.2
Kuo, S.3
Gerfen, C.R.4
Chase, T.N.5
-
15
-
-
79955595805
-
Vascular endothelial growth factor B is neuroprotective in an in vivo model of Parkinson's disease
-
T. Falk, X. Yue, S.L. Zhang, A.D. McCourt, B.J. Yee, R.T. Gonzalez, and S.J. Sherman Vascular endothelial growth factor B is neuroprotective in an in vivo model of Parkinson's disease Neurosci. Lett. 496 2011 43 47
-
(2011)
Neurosci. Lett.
, vol.496
, pp. 43-47
-
-
Falk, T.1
Yue, X.2
Zhang, S.L.3
McCourt, A.D.4
Yee, B.J.5
Gonzalez, R.T.6
Sherman, S.J.7
-
16
-
-
4544255049
-
Non-subtype-selective opioid receptor antagonism in treatment of levodopa-induced motor complications in Parkinson's disease
-
S. Fox, M. Silverdale, M. Kellett, R. Davies, M. Steiger, N. Fletcher, A. Crossman, and J. Brotchie Non-subtype-selective opioid receptor antagonism in treatment of levodopa-induced motor complications in Parkinson's disease Mov. Disord. 19 2004 554 560
-
(2004)
Mov. Disord.
, vol.19
, pp. 554-560
-
-
Fox, S.1
Silverdale, M.2
Kellett, M.3
Davies, R.4
Steiger, M.5
Fletcher, N.6
Crossman, A.7
Brotchie, J.8
-
17
-
-
33750990196
-
Translation of nondopaminergic treatments for levodopa-induced dyskinesia from MPTP-lesioned nonhuman primates to phase IIa clinical studies: Keys to success and roads to failure
-
DOI 10.1002/mds.20936
-
S.H. Fox, A.E. Lang, and J.M. Brotchie Translation of nondopaminergic treatments for levodopa-induced dyskinesia from MPTP-lesioned nonhuman primates to phase IIa clinical studies: keys to success and roads to failure Mov. Disord. 21 2006 1578 1594 (Pubitemid 44742184)
-
(2006)
Movement Disorders
, vol.21
, Issue.10
, pp. 1578-1594
-
-
Fox, S.H.1
Lang, A.E.2
Brotchie, J.M.3
-
18
-
-
84886635094
-
Enhancement of reserpine-elicited dopaminergic supersensitivity by repeated treatment with apomorphine and alpha-methyl-p-tyrosine
-
E. Friedman, J. Rotrosen, M. Gurland, G.A. Lambert, and S. Gershon Enhancement of reserpine-elicited dopaminergic supersensitivity by repeated treatment with apomorphine and alpha-methyl-p-tyrosine Life Sci. 17 1975 867 873
-
(1975)
Life Sci.
, vol.17
, pp. 867-873
-
-
Friedman, E.1
Rotrosen, J.2
Gurland, M.3
Lambert, G.A.4
Gershon, S.5
-
19
-
-
4644264252
-
Mixed opioid receptor agonists as a new class of agents for the treatment of moderate to severe pain
-
K.-J. Chang, F. Porreca, J.H. Woods, Marcel Dekker, Inc New York
-
P.J. Gengo, and K.-J. Chang Mixed opioid receptor agonists as a new class of agents for the treatment of moderate to severe pain K.-J. Chang, F. Porreca, J.H. Woods, The Delta Receptor 2004 Marcel Dekker, Inc New York 231 244
-
(2004)
The Delta Receptor
, pp. 231-244
-
-
Gengo, P.J.1
Chang, K.-J.2
-
20
-
-
0026531301
-
The neostriatal mosaic: Multiple levels of compartmental organization
-
C.R. Gerfen The neostriatal mosaic: multiple levels of compartmental organization Trends Neurosci. 15 1992 133 139
-
(1992)
Trends Neurosci.
, vol.15
, pp. 133-139
-
-
Gerfen, C.R.1
-
21
-
-
0027384928
-
Effect of nondopaminergic drugs on L-DOPA-induced dyskinesias in MPTP- treated monkeys
-
B. Gomez-Mancilla, and P.J. Bedard Effect of nondopaminergic drugs on l-dopa-induced dyskinesias in MPTP-treated monkeys Clin. Neuropharmacol. 16 1993 418 427 (Pubitemid 23292096)
-
(1993)
Clinical Neuropharmacology
, vol.16
, Issue.5
, pp. 418-427
-
-
Gomez-Mancilla, B.1
Bedard, P.J.2
-
22
-
-
0033010166
-
Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat
-
DOI 10.1006/exnr.1998.6996
-
B. Henry, A.R. Crossman, and J.M. Brotchie Effect of repeated l-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat Exp. Neurol. 155 1999 204 220 (Pubitemid 29124714)
-
(1999)
Experimental Neurology
, vol.155
, Issue.2
, pp. 204-220
-
-
Henry, B.1
Crossman, A.R.2
Brotchie, J.M.3
-
23
-
-
0034851915
-
μ- and δ-Opioid receptor antagonists reduce levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease
-
DOI 10.1006/exnr.2001.7727
-
B. Henry, S.H. Fox, A.R. Crossman, and J.M. Brotchie Mu- and delta-opioid receptor antagonists reduce levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease Exp. Neurol. 171 2001 139 146 (Pubitemid 32848452)
-
(2001)
Experimental Neurology
, vol.171
, Issue.1
, pp. 139-146
-
-
Henry, B.1
Fox, S.H.2
Crossman, A.R.3
Brotchie, J.M.4
-
24
-
-
0141672033
-
Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson's disease
-
DOI 10.1016/S0014-4886(03)00064-5
-
B. Henry, S. Duty, S.H. Fox, A.R. Crossman, and J.M. Brotchie Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson's disease Exp. Neurol. 183 2003 458 468 (Pubitemid 37205087)
-
(2003)
Experimental Neurology
, vol.183
, Issue.2
, pp. 458-468
-
-
Henry, B.1
Duty, S.2
Fox, S.H.3
Crossman, A.R.4
Brotchie, J.M.5
-
25
-
-
0035204775
-
Antiparkinsonian action of a δ opioid agonist in rodent and primate models of Parkinson's disease
-
DOI 10.1006/exnr.2001.7763
-
C.J. Hille, S.H. Fox, Y.P. Maneuf, A.R. Crossman, and J.M. Brotchie Antiparkinsonian action of a delta opioid agonist in rodent and primate models of Parkinson's disease Exp. Neurol. 172 2001 189 198 (Pubitemid 33143821)
-
(2001)
Experimental Neurology
, vol.172
, Issue.1
, pp. 189-198
-
-
Hille, C.J.1
Fox, S.H.2
Maneuf, Y.P.3
Crossman, A.R.4
Brotchie, J.M.5
-
26
-
-
0034685961
-
Antiparkinson potential of δ-opioid receptor agonists
-
DOI 10.1016/S0014-2999(00)00209-0, PII S0014299900002090
-
T.J. Hudzik, A. Howell, K. Payza, and A.J. Cross Antiparkinson potential of delta-opioid receptor agonists Eur. J. Pharmacol. 396 2000 101 107 (Pubitemid 30265565)
-
(2000)
European Journal of Pharmacology
, vol.396
, Issue.2-3
, pp. 101-107
-
-
Hudzik, T.J.1
Howell, A.2
Payza, K.3
Cross, A.J.4
-
27
-
-
0036387577
-
Naloxone reduces levodopa-induced dyskinesias and apomorphine-induced rotations in primate models of parkinsonism
-
R. Klintenberg, P. Svenningsson, L. Gunne, and P.E. Andren Naloxone reduces levodopa-induced dyskinesias and apomorphine-induced rotations in primate models of parkinsonism J. Neural Transm. 109 2002 1295 1307
-
(2002)
J. Neural Transm.
, vol.109
, pp. 1295-1307
-
-
Klintenberg, R.1
Svenningsson, P.2
Gunne, L.3
Andren, P.E.4
-
28
-
-
85057699443
-
Biphalin: A multireceptor opioid ligand
-
K.-J. Chang, F. Porreca, J.H. Woods, Marcel Dekker, Inc New York
-
A.W. Lipkowski, D.B. Carr, I. Bonney, and A. Misicka Biphalin: a multireceptor opioid ligand K.-J. Chang, F. Porreca, J.H. Woods, The Delta Receptor 2004 Marcel Dekker, Inc New York 245 261
-
(2004)
The Delta Receptor
, pp. 245-261
-
-
Lipkowski, A.W.1
Carr, D.B.2
Bonney, I.3
Misicka, A.4
-
29
-
-
33847164407
-
Glycosylation improves the central effects of DAMGO
-
DOI 10.1111/j.1747-0285.2007.00462.x
-
J.J. Lowery, L. Yeomans, C.M. Keyari, P. Davis, F. Porreca, B.I. Knapp, J.M. Bidlack, E.J. Bilsky, and R. Polt Glycosylation improves the central effects of DAMGO Chem. Biol. Drug Des. 69 2007 41 47 (Pubitemid 46277779)
-
(2007)
Chemical Biology and Drug Design
, vol.69
, Issue.1
, pp. 41-47
-
-
Lowery, J.J.1
Yeomans, L.2
Keyari, C.M.3
Davis, P.4
Porreca, F.5
Knapp, B.I.6
Bidlack, J.M.7
Bilsky, E.J.8
Polt, R.9
-
30
-
-
79951964544
-
In vivo characterization of MMP-2200, a mixed delta/mu opioid agonist, in mice
-
J.J. Lowery, T.J. Raymond, D. Giuvelis, J.M. Bidlack, R. Polt, and E.J. Bilsky In vivo characterization of MMP-2200, a mixed delta/mu opioid agonist, in mice J. Pharmacol. Exp. Ther. 336 2011 767 778
-
(2011)
J. Pharmacol. Exp. Ther.
, vol.336
, pp. 767-778
-
-
Lowery, J.J.1
Raymond, T.J.2
Giuvelis, D.3
Bidlack, J.M.4
Polt, R.5
Bilsky, E.J.6
-
31
-
-
0035056597
-
High dose naltrexone for dyskinesias induced by levodopa
-
DOI 10.1136/jnnp.70.4.554
-
A.J. Manson, R. Katzenschlager, J. Hobart, and A.J. Lees High dose naltrexone for dyskinesias induced by levodopa J. Neurol. Neurosurg. Psychiatry 70 2001 554 556 (Pubitemid 32269702)
-
(2001)
Journal of Neurology Neurosurgery and Psychiatry
, vol.70
, Issue.4
, pp. 554-556
-
-
Manson, A.J.1
Katzenschlager, R.2
Hobart, J.3
Lees, A.J.4
-
32
-
-
0028908280
-
Preproenkephalin and preprotachykinin messenger RNA expression in normal human basal ganglia and in Parkinson's disease
-
A.P. Nisbet, O.J. Foster, A. Kingsbury, D.J. Eve, S.E. Daniel, C.D. Marsden, and A.J. Lees Preproenkephalin and preprotachykinin messenger RNA expression in normal human basal ganglia and in Parkinson's disease Neuroscience 66 1995 361 376
-
(1995)
Neuroscience
, vol.66
, pp. 361-376
-
-
Nisbet, A.P.1
Foster, O.J.2
Kingsbury, A.3
Eve, D.J.4
Daniel, S.E.5
Marsden, C.D.6
Lees, A.J.7
-
33
-
-
58349115847
-
The basal ganglia in Parkinson's disease: Current concepts and unexplained observations
-
J.A. Obeso, C. Marin, C. Rodriguez-Oroz, J. Blesa, B. Benitez-Temino, J. Mena-Segovia, M. Rodriguez, and C.W. Olanow The basal ganglia in Parkinson's disease: current concepts and unexplained observations Ann. Neurol. 64 Suppl 2 2008 S30 S46
-
(2008)
Ann. Neurol.
, vol.64
, Issue.SUPPL. 2
-
-
Obeso, J.A.1
Marin, C.2
Rodriguez-Oroz, C.3
Blesa, J.4
Benitez-Temino, B.5
Mena-Segovia, J.6
Rodriguez, M.7
Olanow, C.W.8
-
34
-
-
66949117423
-
The scientific and clinical basis for the treatment of Parkinson disease (2009)
-
C.W. Olanow, M.B. Stern, and K. Sethi The scientific and clinical basis for the treatment of Parkinson disease (2009) Neurology 72 2009 S1 S136
-
(2009)
Neurology
, vol.72
-
-
Olanow, C.W.1
Stern, M.B.2
Sethi, K.3
-
36
-
-
0027958852
-
Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease
-
DOI 10.1002/mds.870090410
-
O. Rascol, N. Fabre, O. Blin, J. Poulik, U. Sabatini, J.M. Senard, M. Ane, J.L. Montastruc, and A. Rascol Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease Mov. Disord. 9 1994 437 440 (Pubitemid 24238372)
-
(1994)
Movement Disorders
, vol.9
, Issue.4
, pp. 437-440
-
-
Rascol, O.1
Fabre, N.2
Blin, O.3
Poulik, J.4
Sabatini, U.5
Senard, J.-M.6
Ane, M.7
Montastruc, J.-L.8
Rascol, A.9
-
37
-
-
0035990392
-
Safety and efficacy of controlled-release oxycodone: A systematic literature review
-
D.G. Rischitelli, and S.H. Karbowicz Safety and efficacy of controlled-release oxycodone: a systematic literature review Pharmacotherapy 22 2002 898 904 (Pubitemid 34743439)
-
(2002)
Pharmacotherapy
, vol.22
, Issue.7
, pp. 898-904
-
-
Rischitelli, D.G.1
Karbowicz, S.H.2
-
38
-
-
0142122419
-
Opioid antagonists increase the dyskinetic response to dopaminergic agents in parkinsonian monkeys: Interaction between dopamine and opioid systems
-
DOI 10.1016/S0028-3908(03)00249-1
-
P. Samadi, L. Gregoire, and P.J. Bedard Opioid antagonists increase the dyskinetic response to dopaminergic agents in parkinsonian monkeys: interaction between dopamine and opioid systems Neuropharmacology 45 2003 954 963 (Pubitemid 37297921)
-
(2003)
Neuropharmacology
, vol.45
, Issue.7
, pp. 954-963
-
-
Samadi, P.1
Gregoire, L.2
Bedard, P.J.3
-
39
-
-
33748683820
-
Opioids and motor complications in Parkinson's disease
-
DOI 10.1016/j.tips.2006.08.002, PII S0165614706001829
-
P. Samadi, P.J. Bedard, and C. Rouillard Opioids and motor complications in Parkinson's disease Trends Pharmacol. Sci. 27 2006 512 517 (Pubitemid 44389881)
-
(2006)
Trends in Pharmacological Sciences
, vol.27
, Issue.10
, pp. 512-517
-
-
Samadi, P.1
Bedard, P.J.2
Rouillard, C.3
-
40
-
-
0028220834
-
Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: A combined retrograde tracing and immunocytochemical study in the rat
-
DOI 10.1016/0306-4522(94)90605-X
-
H. Sauer, and W.H. Oertel Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat Neuroscience 59 1994 401 415 (Pubitemid 24098798)
-
(1994)
Neuroscience
, vol.59
, Issue.2
, pp. 401-415
-
-
Sauer, H.1
Oertel, W.H.2
-
41
-
-
33745847479
-
Diagnosis and treatment of Parkinson disease: Molecules to medicine
-
DOI 10.1172/JCI29178
-
J.M. Savitt, V.L. Dawson, and T.M. Dawson Diagnosis and treatment of Parkinson disease: molecules to medicine J. Clin. Investig. 116 2006 1744 1754 (Pubitemid 44033293)
-
(2006)
Journal of Clinical Investigation
, vol.116
, Issue.7
, pp. 1744-1754
-
-
Savitt, J.M.1
Dawson, V.L.2
Dawson, T.M.3
-
42
-
-
0022516918
-
Two automated locomotor activity tests for dopamine autoreceptor agonists
-
P.J. Schreur, and N.F. Nichols Two automated locomotor activity tests for dopamine autoreceptor agonists Pharmacol. Biochem. Behav. 25 1986 255 261 (Pubitemid 16040934)
-
(1986)
Pharmacology Biochemistry and Behavior
, vol.25
, Issue.1
, pp. 255-261
-
-
Schreur, P.J.K.D.1
Nichols, N.F.2
-
43
-
-
0021325819
-
Evidence for a selective processing of proenkephalin B into different opioid peptide forms in particular regions of rat brain and pituitary
-
B.R. Seizinger, C. Grimm, V. Hollt, and A. Herz Evidence for a selective processing of proenkephalin B into different opioid peptide forms in particular regions of rat brain and pituitary J. Neurochem. 42 1984 447 457 (Pubitemid 14180779)
-
(1984)
Journal of Neurochemistry
, vol.42
, Issue.2
, pp. 447-457
-
-
Seizinger, B.R.1
Grimm, C.2
Hollt, V.3
Herz, A.4
|